Aratana Therapeutics
Leawood
About Aratana Therapeutics
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $178.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2018)
- Ticker: nasdaq:PETX
- Website: aratana.com
- Phone: 913-951-2130
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aratana-therapeutics-161275 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.